BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Medilink Midlands - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Medilink Midlands
X-ORIGINAL-URL:https://staging.medilinkmidlands.com
X-WR-CALDESC:Events for Medilink Midlands
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20210916T130000
DTEND;TZID=Europe/London:20210916T140000
DTSTAMP:20260421T092054
CREATED:20210729T073506Z
LAST-MODIFIED:20210729T073506Z
UID:18728-1631797200-1631800800@staging.medilinkmidlands.com
SUMMARY:WEBINAR: Medtech Regulatory Special Interest Group (SIG) – Product traceability and Unique Device Identification for the EU and Global Use
DESCRIPTION:The next MedTech Regulatory Special Interest Group (SIG)\, delivered by regulatory affairs expert Richard Young and GS1 standards professional Chris Florey\, will explore the requirements for product traceability and Unique Identification for the EU and Global Use\, immediate and future considerations for a business. \nThis webinar will cover: \nRichard Young\, AcclaimBiomedical Consulting Ltd:\n– Regulatory background\n– Eudamed\n– MDCG guidance so far \nChris Florey\, GS1 standards professional\, GS1 UK:\n– Basic UDI DI (GMN)\n– UDI-DI and UDI-PI\n– UDI for software as a medical device\n– Human Readable Interpretation (HRI)\n– Barcode verification \nThere will be time at the end of the presentations for a Q&A session. Please submit any questions in advance for Richard and Chris to discuss during the presentation on the online booking form. \nThis free-to-attend event is held as part of the ACTIS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nPlease note: whilst this event is held as part of the ACTIS programme\, attendance is not restricted to companies in the SEMLEP area and is open to all. \nDuration: 1 hour \nTO BOOK YOUR FREE PLACE\, CLICK HERE\nSpeaker Profiles: \n \n  \n  \n  \n  \n  \nRichard Young\, Managing Director\, AcclaimBiomedical Consulting Ltd\nRichard has an extensive background in regulatory affairs in addition to GMP (quality assurance)\, GLP (laboratory testing)\, and GCP (clinical). Spanning over two decades\, these core skill areas have been developed with experience in products ranging from class 3 devices such as Orthopaedic implants (IIb) neurological robots\, through electromedical devices such as infusion systems and cardio vascular products. \nRichard brings a blend of pragmatism and experience to these disciplines that facilitates insightful problem solving approaches as well as solid solutions. \nRichard’s skills and experience includes such areas as the development and implementation of effective quality management systems\, auditing to ISO and FDA QSIT standards\, and operating at national and international level through industry associations including Eucomed\, ABHI and ABHI Technical Policy Group. \n\nChris Florey\, GS1 standards professional\, GS1 UK\nChris has over 15 years experience of working with organisations to adopt GS1 standards to meet trading partner and regulatory requirements\, and his focus for the past eight years has been within the healthcare industry\, assisting medical device and pharmaceutical manufacturers in implementing the NHS eProcurement strategy\, the FDA UDI rules\, the EU MDR and the FMD using GS1 standards. Whilst not a regulatory expert\, he is able to share his experience of engaging with the regulators and thousands of manufacturers and distributors that are GS1 UK members.
URL:https://staging.medilinkmidlands.com/event/webinar-medtech-regulatory-special-interest-group-sig-product-traceability-and-unique-device-identification-for-the-eu-and-global-use/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Chris-Florey.jpg
ORGANIZER;CN="Zoe Heather":MAILTO:info@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20210921T100000
DTEND;TZID=Europe/London:20210921T113000
DTSTAMP:20260421T092054
CREATED:20210809T070122Z
LAST-MODIFIED:20210809T070122Z
UID:18744-1632218400-1632223800@staging.medilinkmidlands.com
SUMMARY:*Cancelled* WEBINAR: The Midlands Ecosystem of Bench to Bedside in the Era of MDR and UKCA
DESCRIPTION:**Unfortunately this event has been cancelled due to unforeseen circumstances. We anticipate that it will take place in early 2022\, details to be released in our fortnightly newsletter in due course**\nThe MedTech and medical devices market for the UK has changed. Companies large and small\, having weathered the impacts of COVID-19\, are now faced with further challenges as the EU’s MDR comes into effect and we march towards the time limit on marketing CE marked devices and in vitro diagnostics within the UK and the introduction of the UKCA. These changes present opportunities but companies will have to be prepared if they are to remain profitable\, whilst both maintaining compliance and in achieving compliance for their new devices and diagnostics. \nFortunately the Midlands boasts a thriving ecosystem of MedTech organisations\, networked to provide end to end support for driving innovations from “bench to bedside”. Companies within the Midlands have a multitude of development services which they can access to help take them from ideation to regulation. This webinar in partnership with the Medical Technologies Innovation Facility (MTIF) aims to highlight these services and map out how to both access them and get the most out of that interaction. \nThere will be an opportunity to put your questions to the presenters in a Q&A session after the presentations. \nDuration 1 hr 30 mins \nThis free-to-attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £190\, but is delivered completely free of charge to participants. \nPlease note: whilst this event is held as part of the INSTILS programme\, attendance is not restricted to companies in the D2N2 area and is open to all. \nSpeaker Profiles  \n \nProfessor Mike Hannay\, Managing Director\, Medical Technologies Innovation Facility (MTIF) – CHAIR \nMike is Managing Director of MTIF based in Nottingham.  Funded by Nottingham Trent University and D2N2 Local Enterprise Partnership MTIF works with partners across the East Midlands to improve the quality of patient care by helping Med-Tech companies accelerate the development and commercial availability of innovative medical technologies and devices \n  \n  \n  \n  \n Deanne Hewson\, Healthcare Technologies Industry Manager\, University of Nottingham \nDeanne Hewson has worked with businesses and universities for over 20 years\, developing knowledge exchange activities and providing business support. Deanne’s current role with the Centre for Healthcare Technologies focuses on delivery of the INSTILS programme\, offering support to SMEs in the D2N2 region to innovate products\, services and processes. \n  \n  \n 
URL:https://staging.medilinkmidlands.com/event/webinar-the-midlands-ecosystem-of-bench-to-bedside-in-the-era-of-mdr-and-ukca/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Deanne-Hewson.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20210922T103000
DTEND;TZID=Europe/London:20210922T113000
DTSTAMP:20260421T092054
CREATED:20210811T144154Z
LAST-MODIFIED:20210811T144154Z
UID:18747-1632306600-1632310200@staging.medilinkmidlands.com
SUMMARY:WEBINAR: Additive Manufacturing & 3D Printing Special Interest Group (SIG)
DESCRIPTION:Join the next online Additive Manufacturing & 3D Printing Special Interest Group\, in partnership with The University of Nottingham – Centre for Additive Manufacturing. \nConfirmed presentation topics: \n– Medical Product Design for Additive Manufacturing\n– How to protect Intellectual Property in Additive Manufacturing innovations\n– Additive Manufacturing of Medical Devices \nDURATION: 1 hour \nThis free to attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nPlease note: whilst this event is held as part of the INSTILS programme\, attendance is not restricted to companies in the D2N2 area and is open to all. \nSpeaker Profiles: \n\nChaired by: Ruth Goodridge\, Professor in Additive Manufacturing (3D Printing)\, The University of Nottingham \nRuth is Professor of Additive Manufacturing (3D-Printing) at the University of Nottingham. She is currently on secondment to Nottingham University Hospitals NHS Trust\, based in Clinical Engineering. With a degree in Biomaterials and PhD in Bioengineering\, she has a particular interest in the medical applications of Additive Manufacturing\, including assistive and rehabilitation devices (inc. prosthetics)\, implants and diagnostics. She has 20 years experience in multidisciplinary research into Additive Manufacturing\, including a 2-year JSPS fellowship held at NAIST\, Japan. Her expertise lies in material development for AM and advancing understanding of coupled material-processing aspects\, in particular for polymer and glass powder bed fusion. \n\nProfessor Richard Bibb\, Professor of Medical Applications of Design\, School of Design & Creative Arts – Loughborough University\nRichard is Professor of Medical Applications of Design in the School of Design & Creative Arts\, Loughborough University. He has more than 20 years’ experience in research exploring the application of Additive Manufacturing and advanced design technologies in surgery\, prosthetics\, orthotics and medical devices. He founded the Medical Applications Group at PDR in 1998 and led it for 10 years. He moved to Loughborough University in 2008 and founded the Digital Design & Fabrication research group in 2014. \n \nGareth Probert\, Partner\, UK and European Patent Attorney\, EIP\nGareth is a partner at the patent firm EIP and heads the EIP HealthTech practice group\, an interdisciplinary team specialising in protecting innovations in the medtech and healthcare sectors. He also focusses on contentious proceedings before the European Patent Office\, often handling multi-party oppositions for commercially significant patents. During his 20-year career in the profession Gareth has gained substantial experience in the medtech and healthcare space\, along with the FMCG\, formulations\, peptide\, food and chemical sectors. \n\nDimitris Katsanis\, Founder & CEO\, Metron Additive Engineering\nDimitris is the founder and CEO of Metron Additive Engineering\, an ISO 13485 and AS9100 certified company\, active in the field of Additive Manufacturing of metallic components.\nSince 2015\, he leads a team of engineers and scientists working on the design and manufacturing of parts used in a variety of industries. In the field of medical implants\, Metron A.E. participated in a variety of custom implants programs together with other world leading companies in the field.
URL:https://staging.medilinkmidlands.com/event/webinar-additive-manufacturing-3d-printing-special-interest-group-sig/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/gareth_probert2.jpg
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20210923T100000
DTEND;TZID=Europe/London:20210923T113000
DTSTAMP:20260421T092054
CREATED:20210729T114030Z
LAST-MODIFIED:20210729T114030Z
UID:18732-1632391200-1632396600@staging.medilinkmidlands.com
SUMMARY:WEBINAR: Infectious Diseases Special Interest Group - The Microbiome: Emerging and Innovative Technologies
DESCRIPTION:Join the next online Infectious Diseases Special Interest Group (SIG)\, this SIG will focus on “The Microbiome: Emerging and Innovative Technologies”. \nRecent advances in microbiome research have highlighted the significant influence these microbial populations have on our wellbeing. The upcoming SIG will be focussing on this rapidly accelerating field\, looking at the role of the microbiome in human health and how imbalances lead to disease. It will also look at the application of emerging technologies that can be used to better understand the microbiome\, and the development of new therapeutic approaches for associated diseases. \nThis event is in partnership with De Montfort University and led by Dr Katie Laird\, Professor of Microbiology and also Head of the Infectious Disease Research Group at De Montfort University. \nConfirmed speaker presentations:\n– Open Innovation in Biofilms R&D: Translation of Academic Research to Address Industry Needs\n– Manipulating respiratory microbiomes: a role for commensals?\n– Labskin: Commercial Skin models to understand the microbial/host interaction\n– Rapid Prototyping of Microfluidic Systems \nDURATION: 1.5 hours \nThis free to attend event is held as part of the SoLSTICE programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £190\, but is delivered completely free of charge to participants. \nPlease note: whilst this event is held as part of the SoLSTICE programme\, attendance is not restricted to companies in the Leicester/Leicestershire region and is open to all. \nSpeaker Profiles: \n\nDr Katie Laird\, Professor of Microbiology and Head of the Infectious Disease Research Group at Leicester School of Pharmacy\, De Montfort University \nKatie has a BSc (Hons) in Biology and obtained a PhD in applied microbiology in 2008. During her PhD she developed and patented an essential oil based antimicrobial vapour\, whilst her postdoctoral work included the assessment of natural antimicrobials efficacy against post-harvest pathogens.\nHer research interests include the use of natural products as antimicrobials in particular to combat hospital acquired infections and biofilms.  Her other area of research includes the assessment of healthcare laundry as a potential route of cross contamination in the clinical arena. \n\nDr Katerina Steventon\, Senior Innovation Consultant\, National Biofilms Innovation Centre\nKaterina is a healthcare specialist with substantial experience of working at the clinical\, commercial and research interface. She holds a MSc in Clinical Biochemistry\, a PhD in Transdermal Absorptions and over 20 years of global work experience in the personal care and wound care industry. Katerina has an in-depth knowledge of skin biology in both its healthy and diseased states. The strengths Katerina brings to NBIC comprise a comprehensive understanding of the industry and academia\, commercialisation of research in a spectrum of healthcare areas and an experience of running an innovation consultancy with a focus on functional skincare.\n \n\nDr David Cleary\, Career Track Post-Doctoral Fellow\, Faculty of Medicine\, University of Southampton and the Southampton NIHR Biomedical Research Centre\nDavid graduated in Medical Microbiology from the University of Surrey in 2002 and went on to complete his PhD with the University of Warwick whilst employed as a microbiologist at the Defence Science and Technology Laboratories (DSTL)\, Porton Down. His current research interests include characterising human respiratory tract microbiomes to determine the microbiota-host interactions that determine colonisation and progression to disease\, as well as understanding the epidemiology of pathogens such as Streptococcus pneumoniae and Non-typeable Haemophilus influenzae. \n\nDr David Caballero-Lima\, Head of R&D\, Labskin\nDavid received his undergraduate degree in Biology and his PhD in Biomedical Sciences from the Universidad de Extremadura in Spain. David took postdoctoral research positions at the University of Sheffield and the University of Manchester\, with both roles focussing on studying human/pathogen interaction via tissue models and obtaining a greater understanding in the regulation of the cell cycle and vesicle transportation during morphological changes.\nDavid was initially Services Manager at Labskin\, bringing his 18 years’ experience working with microbiology and host-pathogen interactions.  As Head of R&D\, David now leads the research department\, focusing on the development of new methods for studying the native skin microflora\, prebiotic\, probiotics and antimicrobial effects of ingredients and formulation for pharmaceutical and cosmeceutical studies. He is also the scientific lead for the development of Labskin new consumers service; Skin Trust Club. David is a key collaborator on international research bids\, as a peer with leading international experts from academia and industry. \n\nPaul Marshall\, Engineering Consultant\, Co-Founder of Rapid Fluidics Ltd\nAn experienced Chartered Mechanical Engineer\, Paul lead the engineering for QuantuMDx Ltd in Newcastle to develop the Q-POC point of care mobile diagnostics system and is now an engineering consultant specialising in Life Sciences. His works covers a wide range of projects from microfluidic instrumentation and consumable systems design for diagnostics through to technical reviews of water\, sanitation and health projects for the Bill and Melinda Gates Foundation. \n\nDr Raymond Allan\, Senior Lecturer in Microbiology\, De Montfort University\nRaymond’s research focusses on the investigation of bacterial biofilms\, developing an understanding of the adaptive mechanisms they employ to enable their survival within the human host\, and their role in chronic infectious disease. His research also includes the identification of targets for the development and investigation of novel treatment strategies for biofilm-associated infections. He has several years’ experience investigating biofilms at University of Southampton\, the National Biofilms Innovation Centre\, and Southampton NIHR Wellcome Trust Clinical Research Facility\, before joining De Montfort University. \n 
URL:https://staging.medilinkmidlands.com/event/webinar-infectious-diseases-special-interest-group-the-microbiome-emerging-and-innovative-technologies/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/David-Caballero.jpg
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
END:VCALENDAR